You are here

  • Home
  • Archive
  • Volume 77, Issue 9
  • Projecting the impact of triple CFTR modulator therapy on intravenous antibiotic requirements in cystic fibrosis using patient registry data combined with treatment effects from randomised trials

Article metrics

Article menu
Cystic fibrosis
Original research
Projecting the impact of triple CFTR modulator therapy on intravenous antibiotic requirements in cystic fibrosis using patient registry data combined with treatment effects from randomised trials

 

Online download statistics by month:

Online download statistics by month: September 2021 to April 2023

AbstractFullPdf
Sep 2021527513115
Oct 202134933496
Nov 202119418078
Dec 202116215736
Jan 202215814452
Feb 20221019969
Mar 202213612866
Apr 202214214042
May 202214412455
Jun 202211711125
Jul 202211211014
Aug 202247046868
Sep 202232932174
Oct 202214313374
Nov 2022918429
Dec 202213012418
Jan 2023756239
Feb 2023969228
Mar 2023817322
Apr 2023383330
Total359534301030